nodes	percent_of_prediction	percent_of_DWPC	metapath
Nefazodone—endogenous depression—Valproic Acid—epilepsy syndrome	0.277	1	CpDpCtD
Nefazodone—ADRA2A—epilepsy syndrome	0.0677	0.306	CbGaD
Nefazodone—Prochlorperazine—Clobazam—epilepsy syndrome	0.0525	1	CrCrCtD
Nefazodone—SLC6A4—epilepsy syndrome	0.0517	0.233	CbGaD
Nefazodone—HTR2A—epilepsy syndrome	0.0397	0.179	CbGaD
Nefazodone—CYP2D6—epilepsy syndrome	0.0363	0.164	CbGaD
Nefazodone—ABCB1—epilepsy syndrome	0.0259	0.117	CbGaD
Nefazodone—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.0123	0.0518	CbGbCtD
Nefazodone—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.0103	0.0433	CbGbCtD
Nefazodone—CYP3A7—Carbamazepine—epilepsy syndrome	0.0103	0.0433	CbGbCtD
Nefazodone—CYP3A7—Phenytoin—epilepsy syndrome	0.00922	0.0389	CbGbCtD
Nefazodone—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.00922	0.0389	CbGbCtD
Nefazodone—ABCB1—Levetiracetam—epilepsy syndrome	0.00874	0.0368	CbGbCtD
Nefazodone—CYP3A7—Phenobarbital—epilepsy syndrome	0.00822	0.0346	CbGbCtD
Nefazodone—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.00822	0.0346	CbGbCtD
Nefazodone—CYP3A7—Midazolam—epilepsy syndrome	0.00811	0.0342	CbGbCtD
Nefazodone—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.00811	0.0342	CbGbCtD
Nefazodone—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.00779	0.0328	CbGbCtD
Nefazodone—CYP3A7—Diazepam—epilepsy syndrome	0.00779	0.0328	CbGbCtD
Nefazodone—CYP3A5—Carbamazepine—epilepsy syndrome	0.00771	0.0325	CbGbCtD
Nefazodone—CYP3A5—Phenytoin—epilepsy syndrome	0.00692	0.0292	CbGbCtD
Nefazodone—CYP3A5—Phenobarbital—epilepsy syndrome	0.00617	0.026	CbGbCtD
Nefazodone—CYP3A5—Midazolam—epilepsy syndrome	0.00608	0.0256	CbGbCtD
Nefazodone—ABCB1—Clobazam—epilepsy syndrome	0.00606	0.0255	CbGbCtD
Nefazodone—CYP3A5—Diazepam—epilepsy syndrome	0.00585	0.0246	CbGbCtD
Nefazodone—ABCB1—Lamotrigine—epilepsy syndrome	0.00583	0.0246	CbGbCtD
Nefazodone—ABCB1—Carbamazepine—epilepsy syndrome	0.00502	0.0212	CbGbCtD
Nefazodone—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00479	0.0202	CbGbCtD
Nefazodone—CYP3A5—Valproic Acid—epilepsy syndrome	0.00461	0.0194	CbGbCtD
Nefazodone—ABCB1—Phenytoin—epilepsy syndrome	0.0045	0.019	CbGbCtD
Nefazodone—CYP3A4—Trimethadione—epilepsy syndrome	0.00445	0.0188	CbGbCtD
Nefazodone—CYP3A4—Felbamate—epilepsy syndrome	0.00445	0.0188	CbGbCtD
Nefazodone—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00419	0.0176	CbGbCtD
Nefazodone—ABCB1—Phenobarbital—epilepsy syndrome	0.00401	0.0169	CbGbCtD
Nefazodone—ABCB1—Midazolam—epilepsy syndrome	0.00396	0.0167	CbGbCtD
Nefazodone—CYP2D6—Propofol—epilepsy syndrome	0.00396	0.0167	CbGbCtD
Nefazodone—ABCB1—Diazepam—epilepsy syndrome	0.00381	0.016	CbGbCtD
Nefazodone—CYP3A4—Clonazepam—epilepsy syndrome	0.00379	0.016	CbGbCtD
Nefazodone—CYP3A4—Clobazam—epilepsy syndrome	0.00363	0.0153	CbGbCtD
Nefazodone—CYP3A4—Rufinamide—epilepsy syndrome	0.00309	0.013	CbGbCtD
Nefazodone—CYP3A4—Carbamazepine—epilepsy syndrome	0.00301	0.0127	CbGbCtD
Nefazodone—CYP3A4—Primidone—epilepsy syndrome	0.00281	0.0118	CbGbCtD
Nefazodone—CYP3A4—Phenytoin—epilepsy syndrome	0.0027	0.0114	CbGbCtD
Nefazodone—CYP3A4—Propofol—epilepsy syndrome	0.00252	0.0106	CbGbCtD
Nefazodone—HTR2A—phrenic nerve—epilepsy syndrome	0.00247	0.0766	CbGeAlD
Nefazodone—CYP3A4—Acetazolamide—epilepsy syndrome	0.00241	0.0101	CbGbCtD
Nefazodone—CYP3A4—Phenobarbital—epilepsy syndrome	0.00241	0.0101	CbGbCtD
Nefazodone—CYP3A4—Midazolam—epilepsy syndrome	0.00237	0.00999	CbGbCtD
Nefazodone—CYP3A4—Diazepam—epilepsy syndrome	0.00228	0.00961	CbGbCtD
Nefazodone—CYP3A4—Zonisamide—epilepsy syndrome	0.00223	0.00938	CbGbCtD
Nefazodone—SLC6A2—locus ceruleus—epilepsy syndrome	0.00183	0.057	CbGeAlD
Nefazodone—CYP3A4—Valproic Acid—epilepsy syndrome	0.0018	0.00757	CbGbCtD
Nefazodone—CYP3A4—Topiramate—epilepsy syndrome	0.00162	0.00683	CbGbCtD
Nefazodone—HTR2A—locus ceruleus—epilepsy syndrome	0.0011	0.0342	CbGeAlD
Nefazodone—SLC6A3—telencephalic ventricle—epilepsy syndrome	0.00108	0.0335	CbGeAlD
Nefazodone—HTR2C—telencephalic ventricle—epilepsy syndrome	0.00104	0.0324	CbGeAlD
Nefazodone—SLC6A2—autonomic nervous system—epilepsy syndrome	0.000974	0.0303	CbGeAlD
Nefazodone—HTR2A—cerebellar cortex—epilepsy syndrome	0.000898	0.0279	CbGeAlD
Nefazodone—HTR1A—telencephalic ventricle—epilepsy syndrome	0.000877	0.0272	CbGeAlD
Nefazodone—HTR2A—vagus nerve—epilepsy syndrome	0.000844	0.0262	CbGeAlD
Nefazodone—SLC6A3—ganglion—epilepsy syndrome	0.000671	0.0208	CbGeAlD
Nefazodone—HTR2C—ganglion—epilepsy syndrome	0.000648	0.0201	CbGeAlD
Nefazodone—HTR2A—pons—epilepsy syndrome	0.000635	0.0197	CbGeAlD
Nefazodone—SLC6A4—ganglion—epilepsy syndrome	0.000615	0.0191	CbGeAlD
Nefazodone—HTR2A—autonomic nervous system—epilepsy syndrome	0.000586	0.0182	CbGeAlD
Nefazodone—HTR1A—ganglion—epilepsy syndrome	0.000546	0.017	CbGeAlD
Nefazodone—SLC6A2—ganglion—epilepsy syndrome	0.000541	0.0168	CbGeAlD
Nefazodone—HTR2A—telencephalic ventricle—epilepsy syndrome	0.000523	0.0162	CbGeAlD
Nefazodone—SLC6A3—hindbrain—epilepsy syndrome	0.000509	0.0158	CbGeAlD
Nefazodone—SLC6A4—hindbrain—epilepsy syndrome	0.000466	0.0145	CbGeAlD
Nefazodone—HTR1A—hindbrain—epilepsy syndrome	0.000414	0.0129	CbGeAlD
Nefazodone—ADRA1A—hindbrain—epilepsy syndrome	0.000382	0.0119	CbGeAlD
Nefazodone—HTR2A—ganglion—epilepsy syndrome	0.000325	0.0101	CbGeAlD
Nefazodone—SLC6A3—brainstem—epilepsy syndrome	0.000292	0.00906	CbGeAlD
Nefazodone—HTR2C—brainstem—epilepsy syndrome	0.000282	0.00876	CbGeAlD
Nefazodone—SLC6A3—forebrain—epilepsy syndrome	0.000281	0.00874	CbGeAlD
Nefazodone—HTR2C—forebrain—epilepsy syndrome	0.000272	0.00845	CbGeAlD
Nefazodone—SLC6A4—brainstem—epilepsy syndrome	0.000267	0.0083	CbGeAlD
Nefazodone—SLC6A3—telencephalon—epilepsy syndrome	0.000259	0.00804	CbGeAlD
Nefazodone—SLC6A4—forebrain—epilepsy syndrome	0.000258	0.00801	CbGeAlD
Nefazodone—HTR2C—telencephalon—epilepsy syndrome	0.00025	0.00777	CbGeAlD
Nefazodone—HTR2A—hindbrain—epilepsy syndrome	0.000247	0.00766	CbGeAlD
Nefazodone—HTR1A—brainstem—epilepsy syndrome	0.000237	0.00737	CbGeAlD
Nefazodone—SLC6A4—telencephalon—epilepsy syndrome	0.000237	0.00737	CbGeAlD
Nefazodone—SLC6A2—brainstem—epilepsy syndrome	0.000235	0.00731	CbGeAlD
Nefazodone—HTR1A—forebrain—epilepsy syndrome	0.000229	0.00711	CbGeAlD
Nefazodone—SLC6A2—forebrain—epilepsy syndrome	0.000227	0.00705	CbGeAlD
Nefazodone—CYP2D6—hindbrain—epilepsy syndrome	0.000225	0.00698	CbGeAlD
Nefazodone—ADRA1A—brainstem—epilepsy syndrome	0.000219	0.00679	CbGeAlD
Nefazodone—ADRA1B—head—epilepsy syndrome	0.000215	0.00668	CbGeAlD
Nefazodone—ADRA1A—forebrain—epilepsy syndrome	0.000211	0.00656	CbGeAlD
Nefazodone—HTR1A—telencephalon—epilepsy syndrome	0.000211	0.00654	CbGeAlD
Nefazodone—SLC6A2—telencephalon—epilepsy syndrome	0.000209	0.00649	CbGeAlD
Nefazodone—ADRA1B—nervous system—epilepsy syndrome	0.000204	0.00634	CbGeAlD
Nefazodone—HTR2C—medulla oblongata—epilepsy syndrome	0.000197	0.00611	CbGeAlD
Nefazodone—ADRA1B—central nervous system—epilepsy syndrome	0.000196	0.0061	CbGeAlD
Nefazodone—ADRA1A—telencephalon—epilepsy syndrome	0.000194	0.00603	CbGeAlD
Nefazodone—SLC6A3—midbrain—epilepsy syndrome	0.000186	0.00577	CbGeAlD
Nefazodone—SLC6A3—spinal cord—epilepsy syndrome	0.000181	0.00563	CbGeAlD
Nefazodone—HTR2C—midbrain—epilepsy syndrome	0.00018	0.00558	CbGeAlD
Nefazodone—HTR2C—spinal cord—epilepsy syndrome	0.000175	0.00544	CbGeAlD
Nefazodone—SLC6A4—midbrain—epilepsy syndrome	0.00017	0.00529	CbGeAlD
Nefazodone—SLC6A4—spinal cord—epilepsy syndrome	0.000166	0.00516	CbGeAlD
Nefazodone—SLC6A2—medulla oblongata—epilepsy syndrome	0.000164	0.0051	CbGeAlD
Nefazodone—SLC6A3—head—epilepsy syndrome	0.000161	0.00501	CbGeAlD
Nefazodone—ADRA2A—forebrain—epilepsy syndrome	0.00016	0.00499	CbGeAlD
Nefazodone—ADRA1B—brain—epilepsy syndrome	0.000156	0.00484	CbGeAlD
Nefazodone—HTR2C—head—epilepsy syndrome	0.000156	0.00484	CbGeAlD
Nefazodone—SLC6A3—nervous system—epilepsy syndrome	0.000153	0.00475	CbGeAlD
Nefazodone—HTR1A—midbrain—epilepsy syndrome	0.000151	0.0047	CbGeAlD
Nefazodone—HTR2C—nervous system—epilepsy syndrome	0.000148	0.00459	CbGeAlD
Nefazodone—SLC6A4—head—epilepsy syndrome	0.000148	0.00459	CbGeAlD
Nefazodone—ADRA2A—telencephalon—epilepsy syndrome	0.000148	0.00458	CbGeAlD
Nefazodone—HTR1A—spinal cord—epilepsy syndrome	0.000148	0.00458	CbGeAlD
Nefazodone—SLC6A3—central nervous system—epilepsy syndrome	0.000147	0.00457	CbGeAlD
Nefazodone—SLC6A3—cerebellum—epilepsy syndrome	0.000144	0.00447	CbGeAlD
Nefazodone—HTR2C—central nervous system—epilepsy syndrome	0.000142	0.00442	CbGeAlD
Nefazodone—HTR2A—brainstem—epilepsy syndrome	0.000141	0.00439	CbGeAlD
Nefazodone—SLC6A4—nervous system—epilepsy syndrome	0.00014	0.00435	CbGeAlD
Nefazodone—HTR2A—forebrain—epilepsy syndrome	0.000136	0.00424	CbGeAlD
Nefazodone—SLC6A4—central nervous system—epilepsy syndrome	0.000135	0.00419	CbGeAlD
Nefazodone—HTR1A—head—epilepsy syndrome	0.000131	0.00407	CbGeAlD
Nefazodone—SLC6A2—head—epilepsy syndrome	0.00013	0.00404	CbGeAlD
Nefazodone—CYP2D6—brainstem—epilepsy syndrome	0.000129	0.004	CbGeAlD
Nefazodone—HTR2A—telencephalon—epilepsy syndrome	0.000125	0.0039	CbGeAlD
Nefazodone—CYP2D6—forebrain—epilepsy syndrome	0.000124	0.00386	CbGeAlD
Nefazodone—HTR1A—nervous system—epilepsy syndrome	0.000124	0.00386	CbGeAlD
Nefazodone—SLC6A2—nervous system—epilepsy syndrome	0.000123	0.00383	CbGeAlD
Nefazodone—ADRA1A—head—epilepsy syndrome	0.000121	0.00375	CbGeAlD
Nefazodone—HTR1A—central nervous system—epilepsy syndrome	0.00012	0.00372	CbGeAlD
Nefazodone—SLC6A2—central nervous system—epilepsy syndrome	0.000119	0.00369	CbGeAlD
Nefazodone—HTR1A—cerebellum—epilepsy syndrome	0.000117	0.00363	CbGeAlD
Nefazodone—SLC6A3—brain—epilepsy syndrome	0.000117	0.00363	CbGeAlD
Nefazodone—ADRA2A—medulla oblongata—epilepsy syndrome	0.000116	0.0036	CbGeAlD
Nefazodone—ADRA1A—nervous system—epilepsy syndrome	0.000115	0.00356	CbGeAlD
Nefazodone—CYP2D6—telencephalon—epilepsy syndrome	0.000114	0.00355	CbGeAlD
Nefazodone—HTR2C—brain—epilepsy syndrome	0.000113	0.00351	CbGeAlD
Nefazodone—ADRA1A—central nervous system—epilepsy syndrome	0.00011	0.00343	CbGeAlD
Nefazodone—ADRA1A—cerebellum—epilepsy syndrome	0.000108	0.00335	CbGeAlD
Nefazodone—SLC6A4—brain—epilepsy syndrome	0.000107	0.00332	CbGeAlD
Nefazodone—ADRA2A—midbrain—epilepsy syndrome	0.000106	0.00329	CbGeAlD
Nefazodone—ADRA2A—spinal cord—epilepsy syndrome	0.000103	0.00321	CbGeAlD
Nefazodone—Aripiprazole—CHRM3—epilepsy syndrome	0.000102	0.051	CrCbGaD
Nefazodone—HTR2A—medulla oblongata—epilepsy syndrome	9.86e-05	0.00306	CbGeAlD
Nefazodone—Aripiprazole—CHRM1—epilepsy syndrome	9.55e-05	0.0476	CrCbGaD
Nefazodone—HTR1A—brain—epilepsy syndrome	9.5e-05	0.00295	CbGeAlD
Nefazodone—SLC6A2—brain—epilepsy syndrome	9.42e-05	0.00293	CbGeAlD
Nefazodone—ADRA2A—head—epilepsy syndrome	9.19e-05	0.00285	CbGeAlD
Nefazodone—HTR2A—midbrain—epilepsy syndrome	9.01e-05	0.0028	CbGeAlD
Nefazodone—ABCB1—forebrain—epilepsy syndrome	8.94e-05	0.00278	CbGeAlD
Nefazodone—HTR2A—spinal cord—epilepsy syndrome	8.79e-05	0.00273	CbGeAlD
Nefazodone—ADRA1A—brain—epilepsy syndrome	8.76e-05	0.00272	CbGeAlD
Nefazodone—ADRA2A—nervous system—epilepsy syndrome	8.71e-05	0.00271	CbGeAlD
Nefazodone—ADRA2A—central nervous system—epilepsy syndrome	8.39e-05	0.00261	CbGeAlD
Nefazodone—ABCB1—telencephalon—epilepsy syndrome	8.22e-05	0.00255	CbGeAlD
Nefazodone—ADRA2A—cerebellum—epilepsy syndrome	8.2e-05	0.00255	CbGeAlD
Nefazodone—HTR2A—head—epilepsy syndrome	7.81e-05	0.00243	CbGeAlD
Nefazodone—Aripiprazole—CHRM2—epilepsy syndrome	7.8e-05	0.0389	CrCbGaD
Nefazodone—Aripiprazole—HTR7—epilepsy syndrome	7.76e-05	0.0387	CrCbGaD
Nefazodone—HTR2A—nervous system—epilepsy syndrome	7.41e-05	0.0023	CbGeAlD
Nefazodone—Zuclopenthixol—ADRA2A—epilepsy syndrome	7.2e-05	0.0359	CrCbGaD
Nefazodone—Hydroxyzine—CYP2D6—epilepsy syndrome	7.17e-05	0.0357	CrCbGaD
Nefazodone—HTR2A—central nervous system—epilepsy syndrome	7.13e-05	0.00222	CbGeAlD
Nefazodone—CYP2D6—head—epilepsy syndrome	7.12e-05	0.00221	CbGeAlD
Nefazodone—HTR2A—cerebellum—epilepsy syndrome	6.97e-05	0.00217	CbGeAlD
Nefazodone—Prochlorperazine—CHRM2—epilepsy syndrome	6.95e-05	0.0346	CrCbGaD
Nefazodone—CYP3A4—nervous system—epilepsy syndrome	6.86e-05	0.00213	CbGeAlD
Nefazodone—CYP2D6—nervous system—epilepsy syndrome	6.75e-05	0.0021	CbGeAlD
Nefazodone—ADRA2A—brain—epilepsy syndrome	6.66e-05	0.00207	CbGeAlD
Nefazodone—Aripiprazole—ADRA2A—epilepsy syndrome	6.65e-05	0.0332	CrCbGaD
Nefazodone—Trazodone—ADRA2A—epilepsy syndrome	6.62e-05	0.033	CrCbGaD
Nefazodone—CYP3A4—central nervous system—epilepsy syndrome	6.6e-05	0.00205	CbGeAlD
Nefazodone—CYP2D6—central nervous system—epilepsy syndrome	6.5e-05	0.00202	CbGeAlD
Nefazodone—ABCB1—medulla oblongata—epilepsy syndrome	6.46e-05	0.00201	CbGeAlD
Nefazodone—Quetiapine—CHRM3—epilepsy syndrome	6.4e-05	0.0319	CrCbGaD
Nefazodone—CYP2D6—cerebellum—epilepsy syndrome	6.35e-05	0.00197	CbGeAlD
Nefazodone—Quetiapine—CHRM1—epilepsy syndrome	5.97e-05	0.0298	CrCbGaD
Nefazodone—ABCB1—midbrain—epilepsy syndrome	5.91e-05	0.00183	CbGeAlD
Nefazodone—ABCB1—spinal cord—epilepsy syndrome	5.76e-05	0.00179	CbGeAlD
Nefazodone—HTR2A—brain—epilepsy syndrome	5.66e-05	0.00176	CbGeAlD
Nefazodone—Fluphenazine—ADRA2A—epilepsy syndrome	5.36e-05	0.0267	CrCbGaD
Nefazodone—CYP2D6—brain—epilepsy syndrome	5.16e-05	0.0016	CbGeAlD
Nefazodone—ABCB1—head—epilepsy syndrome	5.12e-05	0.00159	CbGeAlD
Nefazodone—Aripiprazole—SLC6A4—epilepsy syndrome	5.08e-05	0.0253	CrCbGaD
Nefazodone—Trazodone—SLC6A4—epilepsy syndrome	5.05e-05	0.0252	CrCbGaD
Nefazodone—Trifluoperazine—CHRM2—epilepsy syndrome	5.02e-05	0.025	CrCbGaD
Nefazodone—Perphenazine—HTR7—epilepsy syndrome	4.95e-05	0.0247	CrCbGaD
Nefazodone—Quetiapine—CHRM2—epilepsy syndrome	4.87e-05	0.0243	CrCbGaD
Nefazodone—ABCB1—nervous system—epilepsy syndrome	4.85e-05	0.00151	CbGeAlD
Nefazodone—Quetiapine—HTR7—epilepsy syndrome	4.85e-05	0.0242	CrCbGaD
Nefazodone—ABCB1—central nervous system—epilepsy syndrome	4.67e-05	0.00145	CbGeAlD
Nefazodone—Domperidone—CYP2D6—epilepsy syndrome	4.62e-05	0.023	CrCbGaD
Nefazodone—ABCB1—cerebellum—epilepsy syndrome	4.57e-05	0.00142	CbGeAlD
Nefazodone—Perphenazine—ADRA2A—epilepsy syndrome	4.24e-05	0.0211	CrCbGaD
Nefazodone—Zuclopenthixol—HTR2A—epilepsy syndrome	4.22e-05	0.021	CrCbGaD
Nefazodone—Quetiapine—ADRA2A—epilepsy syndrome	4.16e-05	0.0207	CrCbGaD
Nefazodone—Aripiprazole—HTR2A—epilepsy syndrome	3.9e-05	0.0194	CrCbGaD
Nefazodone—Trazodone—HTR2A—epilepsy syndrome	3.88e-05	0.0194	CrCbGaD
Nefazodone—Zuclopenthixol—CYP2D6—epilepsy syndrome	3.86e-05	0.0192	CrCbGaD
Nefazodone—ABCB1—brain—epilepsy syndrome	3.71e-05	0.00115	CbGeAlD
Nefazodone—Thioproperazine—HTR2A—epilepsy syndrome	3.7e-05	0.0184	CrCbGaD
Nefazodone—Aripiprazole—CYP2D6—epilepsy syndrome	3.57e-05	0.0178	CrCbGaD
Nefazodone—Trazodone—CYP2D6—epilepsy syndrome	3.55e-05	0.0177	CrCbGaD
Nefazodone—Domperidone—ABCB1—epilepsy syndrome	3.3e-05	0.0164	CrCbGaD
Nefazodone—Prochlorperazine—CYP2D6—epilepsy syndrome	3.18e-05	0.0159	CrCbGaD
Nefazodone—Fluphenazine—HTR2A—epilepsy syndrome	3.14e-05	0.0157	CrCbGaD
Nefazodone—Perphenazine—CYP2C19—epilepsy syndrome	3.07e-05	0.0153	CrCbGaD
Nefazodone—Quetiapine—CYP2C19—epilepsy syndrome	3.01e-05	0.015	CrCbGaD
Nefazodone—Fluphenazine—CYP2D6—epilepsy syndrome	2.88e-05	0.0143	CrCbGaD
Nefazodone—Aripiprazole—ABCB1—epilepsy syndrome	2.55e-05	0.0127	CrCbGaD
Nefazodone—Trazodone—ABCB1—epilepsy syndrome	2.54e-05	0.0126	CrCbGaD
Nefazodone—Thioproperazine—ALB—epilepsy syndrome	2.53e-05	0.0126	CrCbGaD
Nefazodone—Trifluoperazine—HTR2A—epilepsy syndrome	2.51e-05	0.0125	CrCbGaD
Nefazodone—Perphenazine—HTR2A—epilepsy syndrome	2.49e-05	0.0124	CrCbGaD
Nefazodone—Quetiapine—HTR2A—epilepsy syndrome	2.44e-05	0.0122	CrCbGaD
Nefazodone—Perphenazine—CYP2D6—epilepsy syndrome	2.27e-05	0.0113	CrCbGaD
Nefazodone—Quetiapine—CYP2D6—epilepsy syndrome	2.23e-05	0.0111	CrCbGaD
Nefazodone—Fluphenazine—ABCB1—epilepsy syndrome	2.05e-05	0.0102	CrCbGaD
Nefazodone—Nausea—Levetiracetam—epilepsy syndrome	1.7e-05	0.000134	CcSEcCtD
Nefazodone—Rash—Vigabatrin—epilepsy syndrome	1.7e-05	0.000134	CcSEcCtD
Nefazodone—Dizziness—Felbamate—epilepsy syndrome	1.7e-05	0.000134	CcSEcCtD
Nefazodone—Dermatitis—Vigabatrin—epilepsy syndrome	1.7e-05	0.000133	CcSEcCtD
Nefazodone—Pruritus—Oxcarbazepine—epilepsy syndrome	1.69e-05	0.000133	CcSEcCtD
Nefazodone—Convulsion—Pregabalin—epilepsy syndrome	1.69e-05	0.000133	CcSEcCtD
Nefazodone—Hypersensitivity—Carbamazepine—epilepsy syndrome	1.69e-05	0.000133	CcSEcCtD
Nefazodone—Vision blurred—Gabapentin—epilepsy syndrome	1.69e-05	0.000133	CcSEcCtD
Nefazodone—Headache—Vigabatrin—epilepsy syndrome	1.69e-05	0.000133	CcSEcCtD
Nefazodone—Hypertension—Pregabalin—epilepsy syndrome	1.69e-05	0.000133	CcSEcCtD
Nefazodone—Vomiting—Diazepam—epilepsy syndrome	1.69e-05	0.000133	CcSEcCtD
Nefazodone—Anorexia—Valproic Acid—epilepsy syndrome	1.68e-05	0.000132	CcSEcCtD
Nefazodone—Tremor—Gabapentin—epilepsy syndrome	1.68e-05	0.000132	CcSEcCtD
Nefazodone—Rash—Diazepam—epilepsy syndrome	1.67e-05	0.000132	CcSEcCtD
Nefazodone—Dermatitis—Diazepam—epilepsy syndrome	1.67e-05	0.000131	CcSEcCtD
Nefazodone—Visual impairment—Topiramate—epilepsy syndrome	1.67e-05	0.000131	CcSEcCtD
Nefazodone—Chest pain—Pregabalin—epilepsy syndrome	1.66e-05	0.000131	CcSEcCtD
Nefazodone—Arthralgia—Pregabalin—epilepsy syndrome	1.66e-05	0.000131	CcSEcCtD
Nefazodone—Myalgia—Pregabalin—epilepsy syndrome	1.66e-05	0.000131	CcSEcCtD
Nefazodone—Ill-defined disorder—Gabapentin—epilepsy syndrome	1.66e-05	0.000131	CcSEcCtD
Nefazodone—Dizziness—Zonisamide—epilepsy syndrome	1.66e-05	0.000131	CcSEcCtD
Nefazodone—Headache—Diazepam—epilepsy syndrome	1.66e-05	0.000131	CcSEcCtD
Nefazodone—Anxiety—Pregabalin—epilepsy syndrome	1.66e-05	0.00013	CcSEcCtD
Nefazodone—Diarrhoea—Clonazepam—epilepsy syndrome	1.66e-05	0.00013	CcSEcCtD
Nefazodone—Anaemia—Gabapentin—epilepsy syndrome	1.66e-05	0.00013	CcSEcCtD
Nefazodone—Hypotension—Valproic Acid—epilepsy syndrome	1.65e-05	0.00013	CcSEcCtD
Nefazodone—Asthenia—Carbamazepine—epilepsy syndrome	1.65e-05	0.00013	CcSEcCtD
Nefazodone—Agitation—Gabapentin—epilepsy syndrome	1.65e-05	0.000129	CcSEcCtD
Nefazodone—Diarrhoea—Phenytoin—epilepsy syndrome	1.65e-05	0.000129	CcSEcCtD
Nefazodone—Discomfort—Pregabalin—epilepsy syndrome	1.64e-05	0.000129	CcSEcCtD
Nefazodone—Nausea—Fosphenytoin—epilepsy syndrome	1.64e-05	0.000129	CcSEcCtD
Nefazodone—Trifluoperazine—ABCB1—epilepsy syndrome	1.64e-05	0.00818	CrCbGaD
Nefazodone—Diarrhoea—Oxcarbazepine—epilepsy syndrome	1.64e-05	0.000129	CcSEcCtD
Nefazodone—Erythema multiforme—Topiramate—epilepsy syndrome	1.64e-05	0.000129	CcSEcCtD
Nefazodone—Angioedema—Gabapentin—epilepsy syndrome	1.64e-05	0.000129	CcSEcCtD
Nefazodone—Hypersensitivity—Lamotrigine—epilepsy syndrome	1.64e-05	0.000129	CcSEcCtD
Nefazodone—Vomiting—Felbamate—epilepsy syndrome	1.63e-05	0.000128	CcSEcCtD
Nefazodone—Dry mouth—Pregabalin—epilepsy syndrome	1.63e-05	0.000128	CcSEcCtD
Nefazodone—Pruritus—Carbamazepine—epilepsy syndrome	1.63e-05	0.000128	CcSEcCtD
Nefazodone—Rash—Felbamate—epilepsy syndrome	1.62e-05	0.000127	CcSEcCtD
Nefazodone—Dermatitis—Felbamate—epilepsy syndrome	1.62e-05	0.000127	CcSEcCtD
Nefazodone—Malaise—Gabapentin—epilepsy syndrome	1.62e-05	0.000127	CcSEcCtD
Nefazodone—Tinnitus—Topiramate—epilepsy syndrome	1.61e-05	0.000127	CcSEcCtD
Nefazodone—Vertigo—Gabapentin—epilepsy syndrome	1.61e-05	0.000127	CcSEcCtD
Nefazodone—Headache—Felbamate—epilepsy syndrome	1.61e-05	0.000126	CcSEcCtD
Nefazodone—Confusional state—Pregabalin—epilepsy syndrome	1.61e-05	0.000126	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	1.61e-05	0.000126	CcSEcCtD
Nefazodone—Flushing—Topiramate—epilepsy syndrome	1.61e-05	0.000126	CcSEcCtD
Nefazodone—Syncope—Gabapentin—epilepsy syndrome	1.61e-05	0.000126	CcSEcCtD
Nefazodone—Leukopenia—Gabapentin—epilepsy syndrome	1.6e-05	0.000126	CcSEcCtD
Nefazodone—Dizziness—Clonazepam—epilepsy syndrome	1.6e-05	0.000126	CcSEcCtD
Nefazodone—Nausea—Vigabatrin—epilepsy syndrome	1.6e-05	0.000126	CcSEcCtD
Nefazodone—Vomiting—Zonisamide—epilepsy syndrome	1.6e-05	0.000126	CcSEcCtD
Nefazodone—Insomnia—Valproic Acid—epilepsy syndrome	1.6e-05	0.000125	CcSEcCtD
Nefazodone—Anaphylactic shock—Pregabalin—epilepsy syndrome	1.59e-05	0.000125	CcSEcCtD
Nefazodone—Oedema—Pregabalin—epilepsy syndrome	1.59e-05	0.000125	CcSEcCtD
Nefazodone—Asthenia—Lamotrigine—epilepsy syndrome	1.59e-05	0.000125	CcSEcCtD
Nefazodone—Quetiapine—ABCB1—epilepsy syndrome	1.59e-05	0.00794	CrCbGaD
Nefazodone—Dizziness—Phenytoin—epilepsy syndrome	1.59e-05	0.000125	CcSEcCtD
Nefazodone—Rash—Zonisamide—epilepsy syndrome	1.58e-05	0.000125	CcSEcCtD
Nefazodone—Infection—Pregabalin—epilepsy syndrome	1.58e-05	0.000125	CcSEcCtD
Nefazodone—Paraesthesia—Valproic Acid—epilepsy syndrome	1.58e-05	0.000125	CcSEcCtD
Nefazodone—Palpitations—Gabapentin—epilepsy syndrome	1.58e-05	0.000124	CcSEcCtD
Nefazodone—Dermatitis—Zonisamide—epilepsy syndrome	1.58e-05	0.000124	CcSEcCtD
Nefazodone—Dizziness—Oxcarbazepine—epilepsy syndrome	1.58e-05	0.000124	CcSEcCtD
Nefazodone—Nausea—Diazepam—epilepsy syndrome	1.58e-05	0.000124	CcSEcCtD
Nefazodone—Loss of consciousness—Gabapentin—epilepsy syndrome	1.57e-05	0.000124	CcSEcCtD
Nefazodone—Headache—Zonisamide—epilepsy syndrome	1.57e-05	0.000124	CcSEcCtD
Nefazodone—Dyspnoea—Valproic Acid—epilepsy syndrome	1.57e-05	0.000124	CcSEcCtD
Nefazodone—Diarrhoea—Carbamazepine—epilepsy syndrome	1.57e-05	0.000124	CcSEcCtD
Nefazodone—Pruritus—Lamotrigine—epilepsy syndrome	1.57e-05	0.000123	CcSEcCtD
Nefazodone—Shock—Pregabalin—epilepsy syndrome	1.57e-05	0.000123	CcSEcCtD
Nefazodone—Somnolence—Valproic Acid—epilepsy syndrome	1.57e-05	0.000123	CcSEcCtD
Nefazodone—Cough—Gabapentin—epilepsy syndrome	1.56e-05	0.000123	CcSEcCtD
Nefazodone—Thrombocytopenia—Pregabalin—epilepsy syndrome	1.56e-05	0.000123	CcSEcCtD
Nefazodone—Tachycardia—Pregabalin—epilepsy syndrome	1.56e-05	0.000122	CcSEcCtD
Nefazodone—Chills—Topiramate—epilepsy syndrome	1.55e-05	0.000122	CcSEcCtD
Nefazodone—Dyspepsia—Valproic Acid—epilepsy syndrome	1.55e-05	0.000122	CcSEcCtD
Nefazodone—Convulsion—Gabapentin—epilepsy syndrome	1.55e-05	0.000122	CcSEcCtD
Nefazodone—Hypertension—Gabapentin—epilepsy syndrome	1.55e-05	0.000122	CcSEcCtD
Nefazodone—Hyperhidrosis—Pregabalin—epilepsy syndrome	1.54e-05	0.000121	CcSEcCtD
Nefazodone—Vomiting—Clonazepam—epilepsy syndrome	1.54e-05	0.000121	CcSEcCtD
Nefazodone—Decreased appetite—Valproic Acid—epilepsy syndrome	1.53e-05	0.000121	CcSEcCtD
Nefazodone—Alopecia—Topiramate—epilepsy syndrome	1.53e-05	0.00012	CcSEcCtD
Nefazodone—Vomiting—Phenytoin—epilepsy syndrome	1.53e-05	0.00012	CcSEcCtD
Nefazodone—Rash—Clonazepam—epilepsy syndrome	1.53e-05	0.00012	CcSEcCtD
Nefazodone—Dermatitis—Clonazepam—epilepsy syndrome	1.53e-05	0.00012	CcSEcCtD
Nefazodone—Arthralgia—Gabapentin—epilepsy syndrome	1.53e-05	0.00012	CcSEcCtD
Nefazodone—Chest pain—Gabapentin—epilepsy syndrome	1.53e-05	0.00012	CcSEcCtD
Nefazodone—Myalgia—Gabapentin—epilepsy syndrome	1.53e-05	0.00012	CcSEcCtD
Nefazodone—Nausea—Felbamate—epilepsy syndrome	1.53e-05	0.00012	CcSEcCtD
Nefazodone—Vomiting—Oxcarbazepine—epilepsy syndrome	1.52e-05	0.00012	CcSEcCtD
Nefazodone—Anxiety—Gabapentin—epilepsy syndrome	1.52e-05	0.00012	CcSEcCtD
Nefazodone—Anorexia—Pregabalin—epilepsy syndrome	1.52e-05	0.00012	CcSEcCtD
Nefazodone—Dizziness—Carbamazepine—epilepsy syndrome	1.52e-05	0.000119	CcSEcCtD
Nefazodone—Diarrhoea—Lamotrigine—epilepsy syndrome	1.52e-05	0.000119	CcSEcCtD
Nefazodone—Headache—Clonazepam—epilepsy syndrome	1.52e-05	0.000119	CcSEcCtD
Nefazodone—Rash—Phenytoin—epilepsy syndrome	1.52e-05	0.000119	CcSEcCtD
Nefazodone—Dermatitis—Phenytoin—epilepsy syndrome	1.52e-05	0.000119	CcSEcCtD
Nefazodone—Rash—Oxcarbazepine—epilepsy syndrome	1.51e-05	0.000119	CcSEcCtD
Nefazodone—Pain—Valproic Acid—epilepsy syndrome	1.51e-05	0.000119	CcSEcCtD
Nefazodone—Constipation—Valproic Acid—epilepsy syndrome	1.51e-05	0.000119	CcSEcCtD
Nefazodone—Dermatitis—Oxcarbazepine—epilepsy syndrome	1.51e-05	0.000119	CcSEcCtD
Nefazodone—Headache—Phenytoin—epilepsy syndrome	1.51e-05	0.000119	CcSEcCtD
Nefazodone—Discomfort—Gabapentin—epilepsy syndrome	1.51e-05	0.000119	CcSEcCtD
Nefazodone—Headache—Oxcarbazepine—epilepsy syndrome	1.5e-05	0.000118	CcSEcCtD
Nefazodone—Nausea—Zonisamide—epilepsy syndrome	1.49e-05	0.000117	CcSEcCtD
Nefazodone—Dry mouth—Gabapentin—epilepsy syndrome	1.49e-05	0.000117	CcSEcCtD
Nefazodone—Hypotension—Pregabalin—epilepsy syndrome	1.49e-05	0.000117	CcSEcCtD
Nefazodone—Flatulence—Topiramate—epilepsy syndrome	1.49e-05	0.000117	CcSEcCtD
Nefazodone—Dysgeusia—Topiramate—epilepsy syndrome	1.48e-05	0.000116	CcSEcCtD
Nefazodone—Confusional state—Gabapentin—epilepsy syndrome	1.47e-05	0.000116	CcSEcCtD
Nefazodone—Dizziness—Lamotrigine—epilepsy syndrome	1.47e-05	0.000115	CcSEcCtD
Nefazodone—Oedema—Gabapentin—epilepsy syndrome	1.46e-05	0.000115	CcSEcCtD
Nefazodone—Anaphylactic shock—Gabapentin—epilepsy syndrome	1.46e-05	0.000115	CcSEcCtD
Nefazodone—Vomiting—Carbamazepine—epilepsy syndrome	1.46e-05	0.000115	CcSEcCtD
Nefazodone—Back pain—Topiramate—epilepsy syndrome	1.46e-05	0.000115	CcSEcCtD
Nefazodone—Feeling abnormal—Valproic Acid—epilepsy syndrome	1.45e-05	0.000114	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	1.45e-05	0.000114	CcSEcCtD
Nefazodone—Infection—Gabapentin—epilepsy syndrome	1.45e-05	0.000114	CcSEcCtD
Nefazodone—Muscle spasms—Topiramate—epilepsy syndrome	1.45e-05	0.000114	CcSEcCtD
Nefazodone—Rash—Carbamazepine—epilepsy syndrome	1.45e-05	0.000114	CcSEcCtD
Nefazodone—Dermatitis—Carbamazepine—epilepsy syndrome	1.45e-05	0.000114	CcSEcCtD
Nefazodone—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	1.44e-05	0.000113	CcSEcCtD
Nefazodone—Insomnia—Pregabalin—epilepsy syndrome	1.44e-05	0.000113	CcSEcCtD
Nefazodone—Nausea—Clonazepam—epilepsy syndrome	1.44e-05	0.000113	CcSEcCtD
Nefazodone—Headache—Carbamazepine—epilepsy syndrome	1.44e-05	0.000113	CcSEcCtD
Nefazodone—Shock—Gabapentin—epilepsy syndrome	1.44e-05	0.000113	CcSEcCtD
Nefazodone—Paraesthesia—Pregabalin—epilepsy syndrome	1.43e-05	0.000113	CcSEcCtD
Nefazodone—Thrombocytopenia—Gabapentin—epilepsy syndrome	1.43e-05	0.000113	CcSEcCtD
Nefazodone—Nausea—Phenytoin—epilepsy syndrome	1.43e-05	0.000112	CcSEcCtD
Nefazodone—Tachycardia—Gabapentin—epilepsy syndrome	1.43e-05	0.000112	CcSEcCtD
Nefazodone—Dyspnoea—Pregabalin—epilepsy syndrome	1.42e-05	0.000112	CcSEcCtD
Nefazodone—Nausea—Oxcarbazepine—epilepsy syndrome	1.42e-05	0.000112	CcSEcCtD
Nefazodone—Vision blurred—Topiramate—epilepsy syndrome	1.42e-05	0.000112	CcSEcCtD
Nefazodone—Somnolence—Pregabalin—epilepsy syndrome	1.42e-05	0.000111	CcSEcCtD
Nefazodone—Hyperhidrosis—Gabapentin—epilepsy syndrome	1.41e-05	0.000111	CcSEcCtD
Nefazodone—Tremor—Topiramate—epilepsy syndrome	1.41e-05	0.000111	CcSEcCtD
Nefazodone—Vomiting—Lamotrigine—epilepsy syndrome	1.41e-05	0.000111	CcSEcCtD
Nefazodone—Urticaria—Valproic Acid—epilepsy syndrome	1.4e-05	0.00011	CcSEcCtD
Nefazodone—Rash—Lamotrigine—epilepsy syndrome	1.4e-05	0.00011	CcSEcCtD
Nefazodone—Ill-defined disorder—Topiramate—epilepsy syndrome	1.4e-05	0.00011	CcSEcCtD
Nefazodone—Dermatitis—Lamotrigine—epilepsy syndrome	1.4e-05	0.00011	CcSEcCtD
Nefazodone—Abdominal pain—Valproic Acid—epilepsy syndrome	1.39e-05	0.00011	CcSEcCtD
Nefazodone—Body temperature increased—Valproic Acid—epilepsy syndrome	1.39e-05	0.00011	CcSEcCtD
Nefazodone—Anorexia—Gabapentin—epilepsy syndrome	1.39e-05	0.00011	CcSEcCtD
Nefazodone—Anaemia—Topiramate—epilepsy syndrome	1.39e-05	0.00011	CcSEcCtD
Nefazodone—Headache—Lamotrigine—epilepsy syndrome	1.39e-05	0.000109	CcSEcCtD
Nefazodone—Decreased appetite—Pregabalin—epilepsy syndrome	1.39e-05	0.000109	CcSEcCtD
Nefazodone—Agitation—Topiramate—epilepsy syndrome	1.39e-05	0.000109	CcSEcCtD
Nefazodone—Hypotension—Gabapentin—epilepsy syndrome	1.37e-05	0.000107	CcSEcCtD
Nefazodone—Nausea—Carbamazepine—epilepsy syndrome	1.36e-05	0.000107	CcSEcCtD
Nefazodone—Pain—Pregabalin—epilepsy syndrome	1.36e-05	0.000107	CcSEcCtD
Nefazodone—Constipation—Pregabalin—epilepsy syndrome	1.36e-05	0.000107	CcSEcCtD
Nefazodone—Malaise—Topiramate—epilepsy syndrome	1.36e-05	0.000107	CcSEcCtD
Nefazodone—Vertigo—Topiramate—epilepsy syndrome	1.35e-05	0.000106	CcSEcCtD
Nefazodone—Syncope—Topiramate—epilepsy syndrome	1.35e-05	0.000106	CcSEcCtD
Nefazodone—Leukopenia—Topiramate—epilepsy syndrome	1.35e-05	0.000106	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	1.33e-05	0.000105	CcSEcCtD
Nefazodone—Palpitations—Topiramate—epilepsy syndrome	1.33e-05	0.000105	CcSEcCtD
Nefazodone—Loss of consciousness—Topiramate—epilepsy syndrome	1.32e-05	0.000104	CcSEcCtD
Nefazodone—Insomnia—Gabapentin—epilepsy syndrome	1.32e-05	0.000104	CcSEcCtD
Nefazodone—Nausea—Lamotrigine—epilepsy syndrome	1.32e-05	0.000104	CcSEcCtD
Nefazodone—Cough—Topiramate—epilepsy syndrome	1.32e-05	0.000103	CcSEcCtD
Nefazodone—Feeling abnormal—Pregabalin—epilepsy syndrome	1.31e-05	0.000103	CcSEcCtD
Nefazodone—Paraesthesia—Gabapentin—epilepsy syndrome	1.31e-05	0.000103	CcSEcCtD
Nefazodone—Convulsion—Topiramate—epilepsy syndrome	1.31e-05	0.000103	CcSEcCtD
Nefazodone—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.3e-05	0.000103	CcSEcCtD
Nefazodone—Dyspnoea—Gabapentin—epilepsy syndrome	1.3e-05	0.000103	CcSEcCtD
Nefazodone—Hypertension—Topiramate—epilepsy syndrome	1.3e-05	0.000102	CcSEcCtD
Nefazodone—Somnolence—Gabapentin—epilepsy syndrome	1.3e-05	0.000102	CcSEcCtD
Nefazodone—Hypersensitivity—Valproic Acid—epilepsy syndrome	1.3e-05	0.000102	CcSEcCtD
Nefazodone—Dyspepsia—Gabapentin—epilepsy syndrome	1.29e-05	0.000101	CcSEcCtD
Nefazodone—Arthralgia—Topiramate—epilepsy syndrome	1.28e-05	0.000101	CcSEcCtD
Nefazodone—Myalgia—Topiramate—epilepsy syndrome	1.28e-05	0.000101	CcSEcCtD
Nefazodone—Chest pain—Topiramate—epilepsy syndrome	1.28e-05	0.000101	CcSEcCtD
Nefazodone—Anxiety—Topiramate—epilepsy syndrome	1.28e-05	0.000101	CcSEcCtD
Nefazodone—Decreased appetite—Gabapentin—epilepsy syndrome	1.27e-05	0.0001	CcSEcCtD
Nefazodone—Discomfort—Topiramate—epilepsy syndrome	1.27e-05	9.97e-05	CcSEcCtD
Nefazodone—Urticaria—Pregabalin—epilepsy syndrome	1.27e-05	9.96e-05	CcSEcCtD
Nefazodone—Asthenia—Valproic Acid—epilepsy syndrome	1.27e-05	9.95e-05	CcSEcCtD
Nefazodone—Body temperature increased—Pregabalin—epilepsy syndrome	1.26e-05	9.91e-05	CcSEcCtD
Nefazodone—Abdominal pain—Pregabalin—epilepsy syndrome	1.26e-05	9.91e-05	CcSEcCtD
Nefazodone—Dry mouth—Topiramate—epilepsy syndrome	1.26e-05	9.87e-05	CcSEcCtD
Nefazodone—Constipation—Gabapentin—epilepsy syndrome	1.25e-05	9.83e-05	CcSEcCtD
Nefazodone—Pain—Gabapentin—epilepsy syndrome	1.25e-05	9.83e-05	CcSEcCtD
Nefazodone—Pruritus—Valproic Acid—epilepsy syndrome	1.25e-05	9.81e-05	CcSEcCtD
Nefazodone—Confusional state—Topiramate—epilepsy syndrome	1.24e-05	9.75e-05	CcSEcCtD
Nefazodone—Oedema—Topiramate—epilepsy syndrome	1.23e-05	9.67e-05	CcSEcCtD
Nefazodone—Infection—Topiramate—epilepsy syndrome	1.22e-05	9.61e-05	CcSEcCtD
Nefazodone—Shock—Topiramate—epilepsy syndrome	1.21e-05	9.52e-05	CcSEcCtD
Nefazodone—Diarrhoea—Valproic Acid—epilepsy syndrome	1.21e-05	9.49e-05	CcSEcCtD
Nefazodone—Feeling abnormal—Gabapentin—epilepsy syndrome	1.21e-05	9.47e-05	CcSEcCtD
Nefazodone—Thrombocytopenia—Topiramate—epilepsy syndrome	1.2e-05	9.47e-05	CcSEcCtD
Nefazodone—Tachycardia—Topiramate—epilepsy syndrome	1.2e-05	9.44e-05	CcSEcCtD
Nefazodone—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.2e-05	9.4e-05	CcSEcCtD
Nefazodone—Hyperhidrosis—Topiramate—epilepsy syndrome	1.19e-05	9.35e-05	CcSEcCtD
Nefazodone—Hypersensitivity—Pregabalin—epilepsy syndrome	1.17e-05	9.24e-05	CcSEcCtD
Nefazodone—Anorexia—Topiramate—epilepsy syndrome	1.17e-05	9.22e-05	CcSEcCtD
Nefazodone—Dizziness—Valproic Acid—epilepsy syndrome	1.17e-05	9.17e-05	CcSEcCtD
Nefazodone—Urticaria—Gabapentin—epilepsy syndrome	1.16e-05	9.13e-05	CcSEcCtD
Nefazodone—Abdominal pain—Gabapentin—epilepsy syndrome	1.16e-05	9.09e-05	CcSEcCtD
Nefazodone—Body temperature increased—Gabapentin—epilepsy syndrome	1.16e-05	9.09e-05	CcSEcCtD
Nefazodone—Hypotension—Topiramate—epilepsy syndrome	1.15e-05	9.04e-05	CcSEcCtD
Nefazodone—Asthenia—Pregabalin—epilepsy syndrome	1.14e-05	9e-05	CcSEcCtD
Nefazodone—Pruritus—Pregabalin—epilepsy syndrome	1.13e-05	8.87e-05	CcSEcCtD
Nefazodone—Vomiting—Valproic Acid—epilepsy syndrome	1.12e-05	8.82e-05	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	1.12e-05	8.81e-05	CcSEcCtD
Nefazodone—Insomnia—Topiramate—epilepsy syndrome	1.11e-05	8.75e-05	CcSEcCtD
Nefazodone—Rash—Valproic Acid—epilepsy syndrome	1.11e-05	8.75e-05	CcSEcCtD
Nefazodone—Dermatitis—Valproic Acid—epilepsy syndrome	1.11e-05	8.74e-05	CcSEcCtD
Nefazodone—Headache—Valproic Acid—epilepsy syndrome	1.11e-05	8.69e-05	CcSEcCtD
Nefazodone—Paraesthesia—Topiramate—epilepsy syndrome	1.1e-05	8.69e-05	CcSEcCtD
Nefazodone—Dyspnoea—Topiramate—epilepsy syndrome	1.1e-05	8.62e-05	CcSEcCtD
Nefazodone—Somnolence—Topiramate—epilepsy syndrome	1.09e-05	8.6e-05	CcSEcCtD
Nefazodone—Diarrhoea—Pregabalin—epilepsy syndrome	1.09e-05	8.58e-05	CcSEcCtD
Nefazodone—Dyspepsia—Topiramate—epilepsy syndrome	1.08e-05	8.52e-05	CcSEcCtD
Nefazodone—Hypersensitivity—Gabapentin—epilepsy syndrome	1.08e-05	8.47e-05	CcSEcCtD
Nefazodone—Decreased appetite—Topiramate—epilepsy syndrome	1.07e-05	8.41e-05	CcSEcCtD
Nefazodone—Dizziness—Pregabalin—epilepsy syndrome	1.05e-05	8.29e-05	CcSEcCtD
Nefazodone—Constipation—Topiramate—epilepsy syndrome	1.05e-05	8.27e-05	CcSEcCtD
Nefazodone—Pain—Topiramate—epilepsy syndrome	1.05e-05	8.27e-05	CcSEcCtD
Nefazodone—Asthenia—Gabapentin—epilepsy syndrome	1.05e-05	8.25e-05	CcSEcCtD
Nefazodone—Nausea—Valproic Acid—epilepsy syndrome	1.05e-05	8.24e-05	CcSEcCtD
Nefazodone—Pruritus—Gabapentin—epilepsy syndrome	1.03e-05	8.13e-05	CcSEcCtD
Nefazodone—Vomiting—Pregabalin—epilepsy syndrome	1.01e-05	7.97e-05	CcSEcCtD
Nefazodone—Feeling abnormal—Topiramate—epilepsy syndrome	1.01e-05	7.97e-05	CcSEcCtD
Nefazodone—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.01e-05	7.91e-05	CcSEcCtD
Nefazodone—Rash—Pregabalin—epilepsy syndrome	1.01e-05	7.91e-05	CcSEcCtD
Nefazodone—Dermatitis—Pregabalin—epilepsy syndrome	1e-05	7.9e-05	CcSEcCtD
Nefazodone—Diarrhoea—Gabapentin—epilepsy syndrome	1e-05	7.87e-05	CcSEcCtD
Nefazodone—Headache—Pregabalin—epilepsy syndrome	9.99e-06	7.86e-05	CcSEcCtD
Nefazodone—Urticaria—Topiramate—epilepsy syndrome	9.77e-06	7.68e-05	CcSEcCtD
Nefazodone—Body temperature increased—Topiramate—epilepsy syndrome	9.73e-06	7.65e-05	CcSEcCtD
Nefazodone—Abdominal pain—Topiramate—epilepsy syndrome	9.73e-06	7.65e-05	CcSEcCtD
Nefazodone—Dizziness—Gabapentin—epilepsy syndrome	9.67e-06	7.6e-05	CcSEcCtD
Nefazodone—Nausea—Pregabalin—epilepsy syndrome	9.47e-06	7.45e-05	CcSEcCtD
Nefazodone—Vomiting—Gabapentin—epilepsy syndrome	9.3e-06	7.31e-05	CcSEcCtD
Nefazodone—Rash—Gabapentin—epilepsy syndrome	9.22e-06	7.25e-05	CcSEcCtD
Nefazodone—Dermatitis—Gabapentin—epilepsy syndrome	9.21e-06	7.24e-05	CcSEcCtD
Nefazodone—Headache—Gabapentin—epilepsy syndrome	9.16e-06	7.2e-05	CcSEcCtD
Nefazodone—Hypersensitivity—Topiramate—epilepsy syndrome	9.06e-06	7.13e-05	CcSEcCtD
Nefazodone—Asthenia—Topiramate—epilepsy syndrome	8.83e-06	6.94e-05	CcSEcCtD
Nefazodone—Pruritus—Topiramate—epilepsy syndrome	8.7e-06	6.84e-05	CcSEcCtD
Nefazodone—Nausea—Gabapentin—epilepsy syndrome	8.69e-06	6.83e-05	CcSEcCtD
Nefazodone—Diarrhoea—Topiramate—epilepsy syndrome	8.42e-06	6.62e-05	CcSEcCtD
Nefazodone—Dizziness—Topiramate—epilepsy syndrome	8.14e-06	6.4e-05	CcSEcCtD
Nefazodone—Vomiting—Topiramate—epilepsy syndrome	7.82e-06	6.15e-05	CcSEcCtD
Nefazodone—Rash—Topiramate—epilepsy syndrome	7.76e-06	6.1e-05	CcSEcCtD
Nefazodone—Dermatitis—Topiramate—epilepsy syndrome	7.75e-06	6.09e-05	CcSEcCtD
Nefazodone—Headache—Topiramate—epilepsy syndrome	7.71e-06	6.06e-05	CcSEcCtD
Nefazodone—Nausea—Topiramate—epilepsy syndrome	7.31e-06	5.75e-05	CcSEcCtD
Nefazodone—HTR1A—Signaling Pathways—MEF2C—epilepsy syndrome	1.85e-06	3.68e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—H2AFX—epilepsy syndrome	1.85e-06	3.67e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—ABCB1—epilepsy syndrome	1.84e-06	3.66e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—MEF2C—epilepsy syndrome	1.84e-06	3.66e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—HBEGF—epilepsy syndrome	1.84e-06	3.65e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—S100B—epilepsy syndrome	1.83e-06	3.63e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—HES1—epilepsy syndrome	1.82e-06	3.62e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—SOCS3—epilepsy syndrome	1.81e-06	3.6e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CDC42—epilepsy syndrome	1.81e-06	3.59e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—AKT3—epilepsy syndrome	1.8e-06	3.58e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—S100B—epilepsy syndrome	1.79e-06	3.56e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—POMC—epilepsy syndrome	1.79e-06	3.56e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—YWHAZ—epilepsy syndrome	1.79e-06	3.56e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	1.79e-06	3.55e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—YWHAZ—epilepsy syndrome	1.78e-06	3.54e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—SOCS3—epilepsy syndrome	1.77e-06	3.52e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—FYN—epilepsy syndrome	1.77e-06	3.52e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—NGF—epilepsy syndrome	1.77e-06	3.52e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CDC42—epilepsy syndrome	1.77e-06	3.52e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—H2AFX—epilepsy syndrome	1.77e-06	3.51e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—MEF2C—epilepsy syndrome	1.76e-06	3.5e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—NGF—epilepsy syndrome	1.76e-06	3.5e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	1.76e-06	3.5e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—ADAM10—epilepsy syndrome	1.76e-06	3.5e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.76e-06	3.49e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—CCL2—epilepsy syndrome	1.75e-06	3.48e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—AVP—epilepsy syndrome	1.75e-06	3.48e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—CAT—epilepsy syndrome	1.74e-06	3.45e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CCR5—epilepsy syndrome	1.72e-06	3.42e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—GPX1—epilepsy syndrome	1.71e-06	3.4e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—AVP—epilepsy syndrome	1.71e-06	3.4e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CCR5—epilepsy syndrome	1.71e-06	3.4e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.71e-06	3.39e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—YWHAZ—epilepsy syndrome	1.71e-06	3.39e-05	CbGpPWpGaD
Nefazodone—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.7e-06	3.38e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	1.7e-06	3.38e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—BCHE—epilepsy syndrome	1.69e-06	3.36e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	1.69e-06	3.36e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—NGF—epilepsy syndrome	1.69e-06	3.35e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—HTR2A—epilepsy syndrome	1.69e-06	3.35e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—HTR2A—epilepsy syndrome	1.68e-06	3.33e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—S100B—epilepsy syndrome	1.66e-06	3.31e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—HES1—epilepsy syndrome	1.66e-06	3.29e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—SOCS3—epilepsy syndrome	1.65e-06	3.27e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CDC42—epilepsy syndrome	1.64e-06	3.27e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CCR5—epilepsy syndrome	1.64e-06	3.26e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—HES1—epilepsy syndrome	1.62e-06	3.22e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	1.62e-06	3.21e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—FYN—epilepsy syndrome	1.61e-06	3.2e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—HTR2A—epilepsy syndrome	1.61e-06	3.19e-05	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—POMC—epilepsy syndrome	1.6e-06	3.19e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—H2AFX—epilepsy syndrome	1.6e-06	3.18e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	1.6e-06	3.18e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—TSC2—epilepsy syndrome	1.6e-06	3.18e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—MEF2C—epilepsy syndrome	1.6e-06	3.18e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—AGT—epilepsy syndrome	1.6e-06	3.18e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PLCB1—epilepsy syndrome	1.6e-06	3.17e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—BCHE—epilepsy syndrome	1.6e-06	3.17e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—TSC2—epilepsy syndrome	1.59e-06	3.16e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—AVP—epilepsy syndrome	1.59e-06	3.16e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—TH—epilepsy syndrome	1.59e-06	3.16e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—AGT—epilepsy syndrome	1.59e-06	3.16e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—FYN—epilepsy syndrome	1.58e-06	3.13e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—GPX1—epilepsy syndrome	1.57e-06	3.12e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—H2AFX—epilepsy syndrome	1.57e-06	3.12e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—MEF2C—epilepsy syndrome	1.57e-06	3.11e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—APOE—epilepsy syndrome	1.57e-06	3.11e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—APOE—epilepsy syndrome	1.56e-06	3.1e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—YWHAZ—epilepsy syndrome	1.55e-06	3.07e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.54e-06	3.07e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.54e-06	3.07e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—KDR—epilepsy syndrome	1.54e-06	3.05e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—NGF—epilepsy syndrome	1.53e-06	3.04e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—KDR—epilepsy syndrome	1.53e-06	3.03e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—TSC2—epilepsy syndrome	1.53e-06	3.03e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—AGT—epilepsy syndrome	1.52e-06	3.03e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	1.52e-06	3.02e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—YWHAZ—epilepsy syndrome	1.51e-06	3.01e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—HES1—epilepsy syndrome	1.51e-06	2.99e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	1.51e-06	2.99e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—AGT—epilepsy syndrome	1.5e-06	2.99e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—TH—epilepsy syndrome	1.5e-06	2.98e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—NGF—epilepsy syndrome	1.5e-06	2.97e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—APOE—epilepsy syndrome	1.49e-06	2.96e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CCR5—epilepsy syndrome	1.49e-06	2.96e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—PRKCB—epilepsy syndrome	1.48e-06	2.94e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—APOE—epilepsy syndrome	1.47e-06	2.93e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—IL6ST—epilepsy syndrome	1.47e-06	2.92e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—PRKCB—epilepsy syndrome	1.47e-06	2.92e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—IL6ST—epilepsy syndrome	1.46e-06	2.91e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—FYN—epilepsy syndrome	1.46e-06	2.91e-05	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—ALB—epilepsy syndrome	1.46e-06	2.9e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—KDR—epilepsy syndrome	1.46e-06	2.9e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—H2AFX—epilepsy syndrome	1.46e-06	2.9e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CCR5—epilepsy syndrome	1.46e-06	2.89e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—MEF2C—epilepsy syndrome	1.46e-06	2.89e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—HTR2A—epilepsy syndrome	1.43e-06	2.83e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—YWHAZ—epilepsy syndrome	1.41e-06	2.8e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—PRKCB—epilepsy syndrome	1.41e-06	2.8e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IL6ST—epilepsy syndrome	1.4e-06	2.78e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—NGF—epilepsy syndrome	1.39e-06	2.76e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—TSC2—epilepsy syndrome	1.38e-06	2.75e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—AGT—epilepsy syndrome	1.38e-06	2.74e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—AGT—epilepsy syndrome	1.38e-06	2.74e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—TSC2—epilepsy syndrome	1.35e-06	2.69e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CCR5—epilepsy syndrome	1.35e-06	2.69e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—APOE—epilepsy syndrome	1.35e-06	2.69e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—AGT—epilepsy syndrome	1.35e-06	2.69e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—APOE—epilepsy syndrome	1.35e-06	2.68e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—POMC—epilepsy syndrome	1.35e-06	2.67e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—POMC—epilepsy syndrome	1.34e-06	2.66e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—HMOX1—epilepsy syndrome	1.33e-06	2.64e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—KDR—epilepsy syndrome	1.33e-06	2.63e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—APOE—epilepsy syndrome	1.33e-06	2.63e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—HTR2A—epilepsy syndrome	1.32e-06	2.63e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CCL2—epilepsy syndrome	1.32e-06	2.62e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—CAT—epilepsy syndrome	1.31e-06	2.6e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CCL2—epilepsy syndrome	1.31e-06	2.6e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—KDR—epilepsy syndrome	1.3e-06	2.58e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—POMC—epilepsy syndrome	1.28e-06	2.55e-05	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	1.28e-06	2.54e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—PRKCB—epilepsy syndrome	1.28e-06	2.54e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IL6ST—epilepsy syndrome	1.27e-06	2.53e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—POMC—epilepsy syndrome	1.27e-06	2.51e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.26e-06	2.5e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—TSC2—epilepsy syndrome	1.26e-06	2.5e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—AGT—epilepsy syndrome	1.26e-06	2.5e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CCL2—epilepsy syndrome	1.25e-06	2.49e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.25e-06	2.49e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—AKT1—epilepsy syndrome	1.25e-06	2.48e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—PRKCB—epilepsy syndrome	1.25e-06	2.48e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IL6ST—epilepsy syndrome	1.25e-06	2.47e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.24e-06	2.45e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—APOE—epilepsy syndrome	1.23e-06	2.45e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.23e-06	2.44e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.22e-06	2.42e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—KDR—epilepsy syndrome	1.21e-06	2.4e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.2e-06	2.39e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	1.19e-06	2.36e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—GPX1—epilepsy syndrome	1.19e-06	2.35e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—FGF2—epilepsy syndrome	1.18e-06	2.35e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—POMC—epilepsy syndrome	1.16e-06	2.31e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—PRKCB—epilepsy syndrome	1.16e-06	2.31e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—POMC—epilepsy syndrome	1.16e-06	2.3e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IL6ST—epilepsy syndrome	1.16e-06	2.3e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—ALB—epilepsy syndrome	1.15e-06	2.29e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—POMC—epilepsy syndrome	1.14e-06	2.26e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	1.14e-06	2.26e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—FGF2—epilepsy syndrome	1.13e-06	2.25e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.12e-06	2.22e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CCL2—epilepsy syndrome	1.11e-06	2.21e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	1.11e-06	2.19e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.1e-06	2.19e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—RELA—epilepsy syndrome	1.1e-06	2.18e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	1.08e-06	2.15e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—MTOR—epilepsy syndrome	1.08e-06	2.14e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	1.06e-06	2.1e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—ALB—epilepsy syndrome	1.06e-06	2.1e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—RELA—epilepsy syndrome	1.05e-06	2.09e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.05e-06	2.08e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.04e-06	2.07e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—AGT—epilepsy syndrome	1.04e-06	2.06e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	1.04e-06	2.06e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—MTOR—epilepsy syndrome	1.03e-06	2.05e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	1.03e-06	2.04e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—APOE—epilepsy syndrome	1.02e-06	2.02e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	1.01e-06	2e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—FGF2—epilepsy syndrome	1.01e-06	2e-05	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.01e-06	2e-05	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—AKT1—epilepsy syndrome	1e-06	1.99e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	9.97e-07	1.98e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	9.95e-07	1.98e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CASP3—epilepsy syndrome	9.92e-07	1.97e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	9.84e-07	1.95e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—TH—epilepsy syndrome	9.81e-07	1.95e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—AGT—epilepsy syndrome	9.8e-07	1.95e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	9.68e-07	1.92e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—JUN—epilepsy syndrome	9.63e-07	1.91e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—APOE—epilepsy syndrome	9.6e-07	1.91e-05	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—AKT1—epilepsy syndrome	9.58e-07	1.9e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	9.55e-07	1.9e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CASP3—epilepsy syndrome	9.49e-07	1.89e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	9.42e-07	1.87e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—MMP9—epilepsy syndrome	9.37e-07	1.86e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	9.36e-07	1.86e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	9.36e-07	1.86e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—RELA—epilepsy syndrome	9.35e-07	1.86e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	9.25e-07	1.84e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—JUN—epilepsy syndrome	9.22e-07	1.83e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—MTOR—epilepsy syndrome	9.17e-07	1.82e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	9.14e-07	1.81e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—AKT1—epilepsy syndrome	9.09e-07	1.81e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—MMP9—epilepsy syndrome	8.97e-07	1.78e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—POMC—epilepsy syndrome	8.75e-07	1.74e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—AKT1—epilepsy syndrome	8.7e-07	1.73e-05	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	8.69e-07	1.73e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	8.69e-07	1.72e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	8.68e-07	1.72e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—SRC—epilepsy syndrome	8.64e-07	1.72e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	8.61e-07	1.71e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	8.52e-07	1.69e-05	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—AKT1—epilepsy syndrome	8.51e-07	1.69e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	8.46e-07	1.68e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CASP3—epilepsy syndrome	8.43e-07	1.67e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—VEGFA—epilepsy syndrome	8.42e-07	1.67e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	8.36e-07	1.66e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—SRC—epilepsy syndrome	8.27e-07	1.64e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—POMC—epilepsy syndrome	8.25e-07	1.64e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—JUN—epilepsy syndrome	8.19e-07	1.63e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	8.19e-07	1.63e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	8.14e-07	1.62e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CAT—epilepsy syndrome	8.08e-07	1.6e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—VEGFA—epilepsy syndrome	8.06e-07	1.6e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—ALB—epilepsy syndrome	7.98e-07	1.58e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—MMP9—epilepsy syndrome	7.97e-07	1.58e-05	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	7.91e-07	1.57e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	7.89e-07	1.57e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	7.86e-07	1.56e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	7.83e-07	1.56e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—AKT1—epilepsy syndrome	7.73e-07	1.53e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	7.61e-07	1.51e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—ALB—epilepsy syndrome	7.52e-07	1.49e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	7.5e-07	1.49e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	7.4e-07	1.47e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—SRC—epilepsy syndrome	7.35e-07	1.46e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	7.31e-07	1.45e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—GPX1—epilepsy syndrome	7.3e-07	1.45e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	7.18e-07	1.43e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—VEGFA—epilepsy syndrome	7.16e-07	1.42e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PTGS2—epilepsy syndrome	6.98e-07	1.39e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	6.83e-07	1.36e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	6.65e-07	1.32e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	6.58e-07	1.31e-05	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—AKT1—epilepsy syndrome	6.43e-07	1.28e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—AGT—epilepsy syndrome	6.41e-07	1.27e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—APOE—epilepsy syndrome	6.28e-07	1.25e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	5.4e-07	1.07e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—POMC—epilepsy syndrome	5.39e-07	1.07e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—AKT1—epilepsy syndrome	5.37e-07	1.07e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—AKT1—epilepsy syndrome	5.14e-07	1.02e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—AKT1—epilepsy syndrome	5.07e-07	1.01e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ALB—epilepsy syndrome	4.92e-07	9.76e-06	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	4.66e-07	9.26e-06	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—AKT1—epilepsy syndrome	4.65e-07	9.23e-06	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—AKT1—epilepsy syndrome	4.57e-07	9.07e-06	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	4.3e-07	8.54e-06	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	4.24e-07	8.42e-06	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—AKT1—epilepsy syndrome	3.51e-07	6.97e-06	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—AKT1—epilepsy syndrome	3.31e-07	6.56e-06	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—AKT1—epilepsy syndrome	2.16e-07	4.29e-06	CbGpPWpGaD
